November 24th 2024
Patients experienced similar safety and efficacy if they received first-line or later-line treatment for unresectable hepatocellular carcinoma (u-HCC).
Dr Michael Diaz on the Importance of Site of Care, PBM Reform
March 17th 2022Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.
Watch
AstraZeneca Receives CRL for Benralizumab in Chronic Rhinosinusitis With Nasal Polyps
March 16th 2022FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.
Read More
More, Better Linkage to Care Needed to Optimize HIV-Related Support Outcomes
March 15th 2022This new meta-analysis from World Health Organization and University of Cape Town investigators analyzed adverse posthospitalization discharge outcomes and related risk factors among persons living with HIV.
Read More
The Economic Impact of Conversion Therapy Harms in the US
March 15th 2022On this episode of Managed Care Cast, Anna Forsythe, PharmD, MSc, MBA, vice president of value and access at Cytel, explains the monetary and humanistic costs of conversion therapy among LGBTQ+ populations in the United States.
Listen
Idaho legislature passed Texas-inspired abortion law banning the procedure after 6 weeks of pregnancy; patients who were bedridden with severe cases of COVID-19 had increased risks of anxiety and depression more than a year later; number of deaths by suicide in Japanese women rose for second straight year.
Read More
Upadacitinib Shows Sustained Efficacy, Safety in Moderate to Severe Atopic Dermatitis
March 15th 2022Longer-term findings of the Measure Up 1 and 2 studies showed the JAK inhibitor upadacitinib to be safe and effective after 52 weeks in the treatment of adults and adolescents with moderate to severe atopic dermatitis.
Read More
Darren Chen: Overall, Patients Were Satisfied With Ophthalmic Video Visits
March 14th 2022A majority of patients with ophthalmic video visits were satisfied, but there were some predictors that contributed to which patients were more satisfied, explained Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
Watch
Dr Kashyap Patel on Health Equity Discussion at the 2022 Community Oncology Conference
March 14th 2022Kashyap Patel, MD, chief executive officer, Carolina Blood and Cancer Care Associations, and current president of the Community Oncology Alliance (COA), previews his discussion on health equity to be held at the 2022 Community Oncology Conference.
Watch
Dr Gregory Vidal: Some Populations Continue to Face Barriers to Care Despite Virtual Options
March 13th 2022Minority, low-income, and elderly patients faced greater barriers to care even when it went virtual during the pandemic, according to Gregory Vidal, MD, PhD, medical oncologist specializing in breast cancer at West Cancer Center.
Watch
Dr Robert Sidbury on Psychosocial, Behavioral Issues Linked With Atopic Dermatitis
March 13th 2022Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, discussed the psychosocial and behavioral issues faced by patients with atopic dermatitis, particularly those with severe disease.
Watch
Study Finds Better Outcomes When Patients Admitted With ARF Have Quick Inter-ICU Transfers
March 11th 2022A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.
Read More
Glenn Balasky Previews Discussion on Building Community Oncology Practice for the Future
March 11th 2022Glenn Balasky, executive director of Rocky Mountain Cancer Centers, previewed topics and potential takeaways from his discussion on building a community oncology practice for the future at the 2022 Community Oncology Conference.
Watch
What We’re Reading: Paying to Quit Substance Use; Census Undercounts; Global COVID-19 Toll
March 11th 2022A new opinion indicates paying those with substance use disorder to stay clean could be legal; the 2020 Census undercounted some racial minorities; the true global COVID-19 death toll could be 3 times higher than the official tally.
Read More
Dr Soumya Chakravarty Discusses Impact of Diagnostic Delays for Psoriatic Arthritis
March 11th 2022Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen, spoke on adverse patient outcomes caused by diagnostic delays in psoriatic arthritis and progress made to address this unmet need.
Read More
Dr David Penberthy on ACCC Presidential Theme, Discussions for Next Year’s Meeting
March 10th 2022David Penberthy, MD, MBA, medical director of radiation oncology at Southside Regional Medical Center, discusses his theme as president-elect of the Association of Community Cancer Centers (ACCC) and what initiatives and discussions he looks forward to addressing over the next year.
Watch